Talimogene Laherparepvec
Showing 1 - 25 of 49
Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),
Recruiting
- Sarcoma
- +2 more
- Talimogene Laherparepvec (T-VEC)
- Pembrolizumab
-
Stanford, California
- +1 more
Feb 2, 2023
Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)
Active, not recruiting
- Breast Cancer
- +3 more
- Talimogene laherparepvec
- Paclitaxel
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022
Stage IV Peritoneal Surface Dissemination From Gastrointestinal or Recurrent, Platinum-resistant Ovarian Cancer That Cannot be
Completed
- Stage IV Peritoneal Surface Dissemination From Gastrointestinal or Recurrent, Platinum-resistant Ovarian Cancer That Cannot be Completely Resected
- Talimogene Laherparepvec
-
Chicago, Illinois
- +2 more
Nov 17, 2022
Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)
Active, not recruiting
- Breast Cancer
- Talimogene laherparepvec
- Atezolizumab
-
Barcelona, Spain
- +3 more
Sep 27, 2022
Soft Tissue Sarcoma Trial in Iowa City (Talimogene Laherparepvec, Radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- Talimogene Laherparepvec
- Radiotherapy
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 4, 2022
Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),
Active, not recruiting
- Melanoma
- +2 more
- TALIMOGENE LAHERPAREPVEC (TVEC)
- Hypofractionated Radiotherapy
-
Middletown, New Jersey
- +2 more
Jul 13, 2022
Soft Tissue Sarcoma Trial in Iowa City (Talimogene Laherparepvec, Radiotherapy)
Active, not recruiting
- Soft Tissue Sarcoma
- Talimogene Laherparepvec
- Radiotherapy
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
May 4, 2022
Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)
Completed
- Unresectable Stage IIIB-IV Malignant Melanoma
- Talimogene laherparepvec
-
Nagoya-shi, Aichi, Japan
- +8 more
Jan 13, 2023
Metastatic Triple Negative Breast Cancer, Metastatic Colorectal Cancer Trial in Worldwide (Talimogene Laherparepvec,
Completed
- Metastatic Triple Negative Breast Cancer
- Metastatic Colorectal Cancer
- Talimogene Laherparepvec
- Atezolizumab
-
Los Angeles, California
- +16 more
Nov 22, 2022
Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))
Completed
- Non-melanoma Skin Cancer
- +4 more
- Talimogene Laherparepvec (T-VEC)
-
Zurich, SwitzerlandDepartment of Dermatology, University Hospital Zurich
Mar 17, 2022
Advanced Non CNS Tumors Trial in Worldwide (Talimogene Laherparepvec)
Completed
- Advanced Non CNS Tumors
- Talimogene Laherparepvec
-
Wilmington, Delaware
- +21 more
Dec 21, 2022
Hepatocellular Carcinoma, Liver Metastases, Cutaneous or Subcutaneous Lymph Node Trial in Worldwide (Talimogene Laherparepvec,
Active, not recruiting
- Hepatocellular Carcinoma
- +3 more
- Talimogene Laherparepvec
- Pembrolizumab
-
Scottsdale, Arizona
- +31 more
Dec 7, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Active, not recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +21 more
- Ipilimumab
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +13 more
- Anastrozole
- +9 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Sarcoma Trial in Santa Monica (Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC], Nivolumab IV Soln 100
Recruiting
- Sarcoma
- Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC]
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Aug 17, 2021
Angiosarcoma of Skin Trial in Tampa (T-VEC)
Active, not recruiting
- Angiosarcoma of Skin
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022
Melanoma and Sarcoma Trial in London (Talimogene laherparepvec (T-VEC))
Completed
- Melanoma and Sarcoma
- Talimogene laherparepvec (T-VEC)
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Aug 17, 2021
Malignant Pleural Effusion, Stage IV Metastatic Cancer, Lung Cancer Trial in Chapel Hill (Talimogene laherparepvec (TVEC),
Terminated
- Malignant Pleural Effusion
- +2 more
- Talimogene laherparepvec (TVEC)
- Nivolumab
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Mar 25, 2021
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)
Squamous Cell Carcinoma, Skin Cancer, Keratoacanthoma Trial in Scottsdale, Tucson (Injection of TVEC into target lesions - week
Recruiting
- Squamous Cell Carcinoma
- +5 more
- Injection of TVEC into target lesions - week 1-2
- +3 more
-
Scottsdale, Arizona
- +1 more
Apr 6, 2022
Unresected Stage IIIb to IVM1c Melanoma Trial in Worldwide (Talimogene Laherparepvec)
Completed
- Unresected Stage IIIb to IVM1c Melanoma
- Talimogene Laherparepvec
-
Salt Lake City, Utah
- +41 more
Nov 26, 2021
Melanoma Trial in Brussels (CD1c (BDCA-1)+ myDC)
Active, not recruiting
- Melanoma
- CD1c (BDCA-1)+ myDC
-
Brussels, BelgiumUZ Brussel
Dec 28, 2020
Carcinoma of the Head and Neck Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab)
Completed
- Carcinoma of the Head and Neck
- Talimogene Laherparepvec
- Pembrolizumab
-
Newark, Delaware
- +32 more
Aug 13, 2021
Melanoma, BRAF Gene Mutation Trial in Germantown (Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,Vil, Talimogene
Unknown status
- Melanoma
- BRAF Gene Mutation
- Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,Vil
- +3 more
-
Germantown, TennesseeWest Cancer Center
Oct 9, 2020